Lead the way to early detection

Mild cognitive impairment (MCI) is the preclinical and transitional stage between healthy aging and dementia with a prevalence estimate of >15% of the global community.5 Memory loss and other cognitive issues may occur due to a variety of reasons that can be treated and managed. Recent studies have shown that 40% of risk factors for dementia are modifiable.1

The Cognivue Thrive® device is a quick, easy-to-administer, cognitive screening tool that provides tangible data points that support clinical recommendations. Differentiate your pharmacy and empower your patients to TAKE ACTION SOONER.

Recent studies have shown that 40% of risk factors for dementia are modifiable1

The EXCEL Program

Cognivue® support every step of the way

  • A step-by-step practice-integration program included with each device
  • Integrate cognitive screening into your workflow with minimal interruption
  • Reduce the learning curve for you and your staff
  • Create clinical and business objectives; track and see results
  • Build confidence in conversations with patients and physicians

Read more clinical articles related to mild cognitive impairment

Cognivue Thrive® is a 5-minute cognitive performance screening tool for non-physicians

Cognivue Clarity® is a 10-minute
cognitive assessment tool for physicians

Patient education on evidence-based ways to manage lifestyle-related risk factors